Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease.

Shambrook P, Hesters A, Marois C, Zemba D, Servan J, Gaymard B, Pico F, Delorme C, Lubetzki C, Arnulf I, Psimaras D, Honnorat J, Gales A, Méneret A.